Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)

BACKGROUND: Selective cyclooxygenase-2 inhibitors and conventional non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs) have been associated with adverse cardiovascular (CV) effects. We compared the CV safety of switching to celecoxib vs. continuing nsNSAID therapy in a European setting. M...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Eur Heart J
Κύριοι συγγραφείς: MacDonald, Thomas M., Hawkey, Chris J., Ford, Ian, McMurray, John J.V., Scheiman, James M., Hallas, Jesper, Findlay, Evelyn, Grobbee, Diederick E., Hobbs, F.D. Richard, Ralston, Stuart H., Reid, David M., Walters, Matthew R., Webster, John, Ruschitzka, Frank, Ritchie, Lewis D., Perez-Gutthann, Susana, Connolly, Eugene, Greenlaw, Nicola, Wilson, Adam, Wei, Li, Mackenzie, Isla S.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2017
Θέματα:
Clinical Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837371/
https://ncbi.nlm.nih.gov/pubmed/27705888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw387
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια